Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Muscle relaxation study for hernia surgery halted before starting

NCT ID NCT03201744

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to compare moderate versus deep muscle relaxation during keyhole surgery for ventral hernias. It planned to see if deeper relaxation allows lower air pressure in the abdomen, improving surgical conditions and patient recovery. However, the study was withdrawn before enrolling any participants, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Aug 2017

Expected to finish

Feb 2022

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients age 18-75 years old * Umbilical, ventral, epigastric, spigelian or incisional hernia * Plan for laparoscopic ventral hernia repair with mesh * Estimated fascial defect between 2-10 cm in maximum diameter Exclusion Criteria: * Allergy to medications delineated in the protocol (muscle blockade, anesthetics, reversal agents) * Inability to provide informed consent * Body mass index of 35 or over * Multiple recurrent hernias (\>1) * Creatinine clearance \< 30 ml/min (using the Cockcroft-Gault calculation)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hernia, ventral are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hernia, Ventral Pneumoperitoneum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stony Brook Hospital

    Stony Brook, New York, 11794-8191, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.